📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
0 analysed today
FollowTelegram
0
Today
152,139
All-time analysed
43,645
Positive
6,747
Negative
92,898
Neutral
8,781
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
129 announcements match the current filters (relevance ≥ 5).
Kilitch Drugs Allots 1.75 Crore Bonus Shares in 1:1 Ratio
Kilitch Drugs (India) Limited has officially approved the allotment of 1,74,80,782 bonus equity shares to its shareholders. The allotment is based on a 1:1 ratio, meaning shareholders receive one new share for every one share held as of the record date, March 24, 2026. This corporate action has resulted in the doubling of the company's paid-up equity share capital from Rs. 17.48 crore to Rs. 34.96 crore. The new shares will rank pari-passu with existing shares, effectively increasing the stock's liquidity in the market.
Key Highlights
Allotment of 1,74,80,782 bonus equity shares with a face value of Rs. 10 each.
Bonus issue ratio maintained at 1:1 for all eligible shareholders as of March 24, 2026.
Total paid-up share capital increased from Rs. 17,48,07,820 to Rs. 34,96,15,640.
Total number of equity shares post-allotment stands at 3,49,61,564.
The board meeting concluded on March 25, 2026, finalizing the issuance process.
👀 What to Watch
Investors should account for the increased share count in their portfolios and the proportional adjustment in the market price. The bonus issue is a positive signal of management's confidence and aims to improve retail participation through better liquidity.
Nitco Limited CFO Bikash Jain Resigns Effective March 31, 2026
Nitco Limited has announced the resignation of Mr. Bikash Jain from the position of Chief Financial Officer (CFO) and Key Managerial Personnel (KMP). The resignation is set to take effect from the close of business hours on March 31, 2026. Mr. Jain cited relocation to Delhi for family reasons and his future plans as the primary motives for his departure. The company has acknowledged his services and will need to initiate the process of appointing a successor to lead its financial operations.
Key Highlights
Mr. Bikash Jain to step down as CFO and KMP effective March 31, 2026
Resignation letter was formally submitted on March 24, 2026
Departure is attributed to personal relocation to Delhi and future career considerations
Mr. Jain also ceases to be a Senior Management Personnel of the company
Company must appoint a new CFO within the statutory timeline to ensure leadership continuity
👀 What to Watch
Investors should monitor the company's upcoming announcements regarding the appointment of a new CFO to ensure a stable transition in financial management. While the resignation appears to be for personal reasons, any delay in finding a replacement should be noted.
Nitco Shareholders Approve Re-appointment of Vivek Talwar as MD and Section 185 Loan Powers
Nitco Limited shareholders have approved the re-appointment of Mr. Vivek Prannath Talwar as Managing Director, designated as Executive Chairman, for a three-year term starting April 1, 2026. Additionally, a special resolution was passed to authorize the company to grant loans, advances, or provide securities under Section 185 of the Companies Act, 2013. Both resolutions received overwhelming support, with over 99.99% of votes cast in favor. This ensures leadership continuity and provides the board with necessary financial flexibility for corporate transactions.
Key Highlights
Re-appointment of Vivek Prannath Talwar as MD for a 3-year term effective April 2026 approved with 99.998% votes.
Special resolution for Section 185 (loans, guarantees, and securities) passed with 15,43,97,023 votes in favor.
A total of 14,45,76,538 valid votes were polled for the MD re-appointment resolution.
The voting process was conducted via remote e-voting from February 19 to March 20, 2026, involving 26,368 eligible shareholders.
👀 What to Watch
Investors should note the leadership continuity as a positive for stability, but should monitor future filings for any specific related-party loans or guarantees issued under the approved Section 185 powers.
NITCO Allots 1.14 Cr Shares to Promoter at Rs 92.25; Raises Rs 78.87 Cr via Warrant Conversion
Nitco Limited has allotted 1.14 crore equity shares to its promoter, Mr. Vivek Prannath Talwar, following the exercise of convertible warrants. The shares were issued at a price of Rs. 92.25 per share, resulting in a fresh capital infusion of approximately Rs. 78.87 crore representing the 75% balance payment. This conversion has significantly increased the promoter's individual stake in the company from 4.29% to 8.82%. The company still has 1.20 crore warrants pending for conversion before the July 2026 deadline.
Key Highlights
Allotment of 1,14,00,000 equity shares to Promoter Mr. Vivek Prannath Talwar at Rs. 92.25 per share.
Company received Rs. 78.87 crore as the balance 75% subscription amount for the exercised warrants.
Promoter's individual shareholding increased from 4.29% to 8.82% post-allotment.
A total of 1,20,10,000 warrants remain outstanding and are eligible for conversion until July 26, 2026.
Board approved material related party transactions with Authum Investments & Infrastructure for FY 2026-27.
👀 What to Watch
The promoter's increased stake and the substantial capital infusion are positive signals regarding the company's internal confidence. Investors should monitor how this liquidity is used to improve the balance sheet or fund expansion.
Nitco Allots 1.14 Cr Equity Shares to Promoter; Raises ₹78.87 Cr via Warrant Conversion
Nitco Limited has allotted 1.14 crore equity shares to its promoter, Mr. Vivek Prannath Talwar, following the conversion of share warrants issued in January 2025. This conversion has brought in approximately ₹78.87 crore, representing the 75% balance payment of the ₹92.25 issue price. As a result, the promoter's individual stake in the company has increased significantly from 4.29% to 8.82%. The company also announced proposed material related party transactions with Authum Investments & Infrastructure for FY 2026-27, pending shareholder approval.
Key Highlights
Allotment of 1,14,00,000 equity shares at an issue price of ₹92.25 per share (including ₹82.25 premium).
Total capital infusion of ₹78,87,37,500 received as the 75% balance subscription amount.
Promoter Vivek Prannath Talwar's shareholding increased from 4.29% to 8.82% post-allotment.
1,20,10,000 warrants remain outstanding for conversion by the July 26, 2026 deadline.
Board approved a postal ballot for material related party transactions with Authum Investments & Infrastructure Limited.
👀 What to Watch
The substantial increase in promoter stake and the fresh capital infusion are positive indicators of management's commitment to the company's turnaround. Investors should monitor the upcoming postal ballot regarding related party transactions and the utilization of the newly raised funds.
Kilitch Drugs Sets March 24, 2026 as Record Date for 1:1 Bonus Issue
Kilitch Drugs (India) Limited has officially announced March 24, 2026, as the record date for its 1:1 bonus share issue. Shareholders holding the company's equity shares of face value Rs. 10 each as of the record date will be eligible to receive one additional share for every share held. The deemed date for the allotment of these bonus shares is set for March 25, 2026. This move follows the necessary shareholder approvals and aims to increase the liquidity of the stock in the market.
Key Highlights
Bonus issue ratio of 1:1 (one new share for every one existing share held)
Record date for determining eligibility is Tuesday, March 24, 2026
Deemed date of allotment for bonus shares is Wednesday, March 25, 2026
Face value of the equity shares remains at Rs. 10 per share
👀 What to Watch
Existing shareholders should hold their positions through the record date to receive the bonus shares. New investors should be aware that the stock price will adjust downwards proportionally on the ex-bonus date.
MITCON to Acquire 49% Stake in Two MINVEN Solar SPVs at Face Value
MITCON Consultancy & Engineering Services has signed agreements to acquire a 49% stake in two special purpose vehicles, MINVEN Solar 02 and MINVEN Solar 03. The acquisition will be executed at a face value of Rs. 10 per share through cash consideration and is expected to be completed within 60 days. Both target entities are early-stage companies incorporated in December 2024, focusing on solar power generation, infrastructure, and consultancy. This move is part of MITCON's strategic intent to expand its renewable energy asset portfolio.
Key Highlights
Acquisition of 49% stake in MINVEN Solar 02 and MINVEN Solar 03 Private Limited.
Transaction to be completed at face value of Rs. 10 per share via cash consideration.
Target entities are newly incorporated (Dec 2024) with nil turnover as of March 2025.
The acquisition aims to grow MITCON's solar asset portfolio and renewable energy footprint.
Completion of the transaction is scheduled within 60 days from March 16, 2026.
👀 What to Watch
Investors should monitor the operational progress of these SPVs and their ability to secure Power Purchase Agreements (PPAs). The entry at face value represents a low-cost strategic expansion into the renewable infrastructure sector.
MITCON to Acquire 49% Stake in Two MINVEN Solar SPVs at Face Value
MITCON Consultancy & Engineering Services has executed agreements to acquire a 49% stake in two solar power Special Purpose Vehicles (SPVs), MINVEN Solar 02 and MINVEN Solar 03. The acquisition will be completed at a face value of Rs. 10 per share through cash consideration, with a target completion timeline of 60 days. Both target entities are newly incorporated (December 2024) and reported nil turnover for the period ending March 2025. This move is part of MITCON's strategic intent to expand its solar asset portfolio and renewable energy consultancy business.
Key Highlights
Acquisition of 49% stake in MINVEN Solar 02 and MINVEN Solar 03 Private Limited
Transaction to be executed at face value of Rs. 10 per share via cash consideration
Target entities are early-stage solar ventures incorporated in December 2024 with nil turnover
Acquisition expected to be completed within 60 days subject to conditions precedent
Strategic alignment to grow the company's solar asset and renewable energy portfolio
👀 What to Watch
Investors should view this as a long-term strategic expansion into the renewable energy sector at a low entry cost. Monitor the execution of these projects as they transition from incorporation to operational status to assess future revenue impact.
Kilitch Drugs Approves 1:1 Bonus Issue and Increase in Authorized Capital at EGM
Kilitch Drugs (India) Limited successfully conducted its Extraordinary General Meeting (EGM) on March 13, 2026. Shareholders approved the issuance of bonus shares in a 1:1 ratio, meaning investors will receive one additional share for every share held. The meeting also authorized an increase in the company's share capital and necessary amendments to the Memorandum of Association. The record date for the bonus allotment will be determined and announced by the Board in due course.
Key Highlights
Approval of 1:1 Bonus Issue for all eligible shareholders as of the upcoming record date
Resolution passed to increase the Authorized Capital of the company and amend the Memorandum of Association
EGM held on March 13, 2026, with participation from 3 promoter group members and 45 public shareholders
The meeting was conducted via video conferencing and concluded within 12 minutes with all resolutions transacted
👀 What to Watch
Existing shareholders should monitor for the announcement of the record date to ensure eligibility for the 1:1 bonus shares. Note that while share count will double, the stock price will adjust proportionally on the ex-bonus date.
Kilitch Drugs Approves 1:1 Bonus Issue and Capital Increase at EGM
Kilitch Drugs (India) Limited successfully conducted an Extraordinary General Meeting on March 13, 2026. The shareholders approved a 1:1 bonus share issue, which will double the total number of equity shares. Additionally, the company received approval to increase its authorized share capital to support the bonus issuance. The Board of Directors will determine the record date for the allotment in due course.
Key Highlights
Approved 1:1 bonus share issuance to existing shareholders as of the upcoming record date.
Authorized the increase of the company's share capital and subsequent amendment of the Memorandum of Association.
The EGM was held via video conferencing with participation from 48 members (3 promoters and 45 public).
The meeting was brief, commencing at 11:30 am and concluding at 11:42 am on March 13, 2026.
👀 What to Watch
Investors should track the upcoming announcement regarding the record date to qualify for the 1:1 bonus. Note that the stock price will adjust proportionally on the ex-bonus date to reflect the increased share count.
Ritco Logistics Secures ₹104 Cr New Contracts in Feb 2026; TrucksUp FASTag GMV Hits ₹15 Cr
Ritco Logistics secured new transportation contracts totaling approximately ₹104.18 crore in February 2026, anchored by a major ₹84 crore, 3-year deal with Jindal Stainless. The company's digital arm, TrucksUp, demonstrated significant traction with FASTag GMV surpassing ₹15 crore and transaction volumes growing 52% month-on-month. Diversification remains strong with new wins across steel, FMCG, and chemicals, while the service network now covers over 17,000 pin codes. These updates indicate robust execution and improving digital adoption, providing high revenue visibility for the coming quarters.
Key Highlights
Secured new transportation contracts worth ~₹104.18 crore in February 2026 across multiple sectors.
Won a significant 3-year strategic contract from Jindal Stainless Limited (JSL) valued at ~₹84 crore.
TrucksUp platform FASTag GMV exceeded ₹15 crore with a 52% month-on-month growth in transactions.
Expanded service reach to 17,000+ pin codes and issued over 6,000 digital fuel cards to customers.
Load Board engagement increased with 'Find Load' activity growing by 32% and 'Add Load' by 23% MoM.
👀 What to Watch
Investors should note the strong order book and the rapid scaling of the TrucksUp digital platform as key drivers for future growth. The long-term revenue visibility from the Jindal Stainless contract provides a stable foundation for the transportation vertical.
Nitco Ltd Q3 Results: Board Re-appoints Chairman & Approves ₹100 Cr Inter-Corporate Loans
Nitco Limited's board has approved the re-appointment of Vivek Prannath Talwar as Executive Chairman for a three-year term starting April 2026. The company is seeking shareholder approval to provide loans or guarantees up to ₹100 Crores to subsidiaries and related entities. Financial results for Q3 FY26 include an ESOP expense of ₹779.07 lakhs and a one-time exceptional charge of ₹400.13 lakhs for labor code adjustments. A significant contingent liability of ₹17,000 lakhs related to an ADGFT penalty remains unprovided for, which the management is currently contesting.
Key Highlights
Re-appointment of Vivek Prannath Talwar as Executive Chairman for a 3-year period effective April 1, 2026.
Approval to provide loans, guarantees, or securities to group entities up to an aggregate limit of ₹100 Crores.
Exceptional item of ₹400.13 lakhs recognized due to gratuity and leave liability changes under the New Labour Code.
Contingent liability of ₹17,000 lakhs from ADGFT penalty not provided for in books based on legal opinion.
Alibaug factory assets reclassified as 'Held for Sale' following a binding scrap-sale offer of ₹3,250 lakhs.
👀 What to Watch
Investors should exercise caution regarding the ₹17,000 lakh unprovided penalty which could severely impact the balance sheet if realized. Monitor the upcoming postal ballot regarding the ₹100 crore inter-corporate loan limit for potential related-party transaction risks.
Nitco Seeks Shareholder Nod for MD Re-appointment and ₹100 Crore Loan Limit
Nitco Limited has issued a postal ballot notice to seek approval for the re-appointment of Mr. Vivek Prannath Talwar as Executive Chairman for a three-year term starting April 2026. Notably, Mr. Talwar has voluntarily waived his remuneration for this period, which is a positive sign for the company's cost management. Additionally, the company is seeking authorization to provide loans, guarantees, or securities up to an aggregate of ₹100 Crores to its subsidiaries and group entities. The remote e-voting period for these special resolutions is scheduled from February 19 to March 20, 2026.
Key Highlights
Proposed re-appointment of Mr. Vivek Prannath Talwar as Managing Director for 3 years effective April 1, 2026.
Mr. Talwar has voluntarily waived his remuneration for the proposed term, receiving only statutory benefits and reimbursements.
Seeking approval for a ₹100 Crore aggregate limit for loans, guarantees, and securities to group entities under Section 185.
Special resolution required to allow Mr. Talwar to continue his directorship beyond the age of 70 years.
E-voting results are expected to be announced on or before March 24, 2026.
👀 What to Watch
Investors should monitor the allocation of the ₹100 Crore loan limit to ensure it does not lead to excessive related-party exposure. The MD's waiver of remuneration is a positive gesture of commitment to the company's financial stability.
Kilitch Drugs Announces 1:1 Bonus Issue and Increase in Authorized Capital
Kilitch Drugs (India) Limited has scheduled an Extraordinary General Meeting (EGM) on March 13, 2026, to seek shareholder approval for a 1:1 bonus share issuance. The company plans to capitalize up to INR 17.48 crore from its Free Reserves or Securities Premium to issue approximately 1.75 crore new equity shares. To facilitate this, the authorized share capital will be increased from INR 25 crore to INR 40 crore. Shareholders on record as of March 4, 2026, will be eligible for e-voting on these proposals.
Key Highlights
Proposed 1:1 bonus issue, providing one new equity share for every one existing share held
Increase in Authorized Share Capital from INR 25,00,00,000 to INR 40,00,00,000
Capitalization of a sum not exceeding INR 17,48,07,820 from reserves for the bonus issue
EGM to be held on March 13, 2026, with remote e-voting from March 9 to March 12, 2026
Cut-off date for determining e-voting eligibility is March 4, 2026
👀 What to Watch
Investors should monitor the official announcement of the Record Date following the EGM approval to ensure eligibility for the bonus shares. While the number of shares will double, the stock price will adjust proportionally, improving liquidity for retail participants.
NITCO Q3 FY26 Revenue Rises 56% YoY to ₹131 Cr; Targets ₹1,000 Cr Real Estate Monetization
NITCO Limited reported a robust 56% YoY revenue growth in its core tiles, marble, and mosaic business for Q3 FY26, reaching ₹131.18 crore. The company is executing a turnaround strategy supported by Authum Investment, which has restructured debt and provided working capital. A major highlight is the company's 445-acre land bank, with plans to unlock over ₹1,000 crore in cash flow over the next 3-5 years through monetization and joint developments. While the company still reports a net loss, EBITDA margins are showing improvement, and the institutional pipeline is strong with ₹280 crore in LoIs from major developers.
Key Highlights
Q3 FY26 revenue from operations grew 56% YoY to ₹131.18 crore, with 9M FY26 revenue up 77% to ₹387.97 crore.
Real estate division targets unlocking ₹1,000+ crore in cash flow over 3-5 years from a 445-acre land bank.
Received Letters of Intent (LoIs) from Prestige Estates and Lodha Group for orders worth approximately ₹280 crore.
Authum Investment & Infrastructure Limited holds a 49% stake, providing strategic debt restructuring and capital infusion.
Projected revenue for FY26 is ₹450 crore, with a long-term target of ₹1,000 crore revenue and 10% EBITDA by FY29.
👀 What to Watch
Investors should focus on the company's ability to execute its real estate monetization plan, as this cash flow is critical for debt reduction and growth. The strong institutional order pipeline and backing from Authum suggest a potential turnaround, though the company remains in a loss-making phase.
Nitco Re-appoints Vivek Talwar as Executive Chairman; Approves ₹100 Cr Related Party Funding
Nitco Limited has re-appointed Mr. Vivek Prannath Talwar as Managing Director and Executive Chairman for a three-year term starting April 2026. The board also approved providing loans or guarantees to subsidiaries and related entities up to an aggregate limit of ₹100 Crores. Financially, the company reported an exceptional item of ₹400.13 lakhs due to the New Labour Code's impact on employee benefits. Notably, the statutory auditors highlighted a significant unprovided penalty of ₹17,000 lakhs from ADGFT, which the management is currently contesting.
Key Highlights
Re-appointment of Vivek Prannath Talwar as Executive Chairman for 3 years effective April 1, 2026.
Board approval for loans and guarantees to related entities up to a limit of ₹100 Crores.
Exceptional charge of ₹400.13 lakhs recognized for gratuity and leave liability under the New Labour Code.
Auditors flagged a ₹17,000 lakh penalty from ADGFT and a ₹855.22 lakh capital advance as unprovided for.
ESOP expense of ₹779.07 lakhs recognized for the period August 2024 to December 2025.
👀 What to Watch
Investors should closely monitor the outcome of the ₹17,000 crore ADGFT penalty appeal, as it represents a massive contingent liability relative to the company's size. The ₹100 crore related party funding limit also warrants caution regarding future capital allocation and corporate governance.
Nitco Ltd Q3 Results: Board Approves ₹100 Cr Loan Limit and Re-appoints Executive Chairman
Nitco Limited's board met on February 12, 2026, to approve Q3 financial results and several strategic mandates. Key decisions include the re-appointment of Mr. Vivek Talwar as Executive Chairman for three years and seeking shareholder approval for a ₹100 crore limit for loans and guarantees to subsidiaries. The company is currently managing a significant contingent liability of ₹17,000 lakhs related to an ADGFT penalty, which management is contesting. Additionally, the company recognized a ₹400.13 lakh exceptional cost due to New Labour Code adjustments.
Key Highlights
Approved re-appointment of Vivek Prannath Talwar as Executive Chairman for a 3-year term starting April 2026.
Proposed a ₹100 crore aggregate limit for loans, guarantees, or securities to subsidiaries and group entities.
Disclosed a ₹17,000 lakh penalty from ADGFT which is being contested; no provision has been made in the books.
Recognized an exceptional item of ₹400.13 lakhs for increased gratuity and leave liability under the New Labour Code.
Allotted 56,000 equity shares during the quarter following the exercise of vested employee stock options.
👀 What to Watch
Investors should exercise caution regarding the ₹17,000 lakh ADGFT penalty, as an adverse final legal outcome could significantly impact the balance sheet. Monitor the progress of the Alibaug asset disposal and the utilization of the new ₹100 crore inter-corporate loan limit.
Ritco Logistics Q3 FY26: Revenue Jumps 25% YoY to ₹394 Cr; 9M Revenue Crosses ₹1100 Cr
Ritco Logistics delivered a strong top-line performance in Q3 FY26, with consolidated revenue increasing 25.31% YoY to ₹394.01 Cr. Standalone net profit grew 5.83% YoY to ₹13.79 Cr, although consolidated net profit dipped 5.12% YoY to ₹9.64 Cr, likely due to continued investments in its digital and multimodal segments. The company's 9M FY26 consolidated revenue showed robust growth of 31.06%, reaching ₹1111.47 Cr. Strategic wins in steel, polymers, and multimodal logistics, alongside a 73% QoQ revenue surge in its digital arm 'TrucksUp', highlight a successful transition toward a tech-enabled logistics provider.
Key Highlights
Consolidated Total Income rose 25.31% YoY to ₹394.01 Cr in Q3 FY26.
9M FY26 Consolidated Revenue crossed ₹1111 Cr, marking a 31.06% YoY growth.
Standalone Net Profit increased 5.83% YoY to ₹13.79 Cr, reflecting core operational strength.
Digital division 'TrucksUp' reported a significant 73.45% QoQ revenue growth to ₹3.92 Cr.
Secured multiple high-value contracts in Steel, Polymer, and Infrastructure sectors during the quarter.
👀 What to Watch
Investors should monitor the scaling of the 'TrucksUp' digital platform and its eventual path to profitability at the consolidated level. The strong top-line momentum and diversification into high-value industrial segments like steel and polymers are positive indicators for long-term growth.
Kilitch Drugs Announces 1:1 Bonus Issue and Q3 FY26 Results; Revenue Jumps 170% YoY
Kilitch Drugs (India) Limited has recommended a 1:1 bonus issue, providing one free equity share for every share held, subject to shareholder approval. For Q3 FY26, the company reported a massive 170% year-on-year surge in standalone revenue to ₹44.67 crore, although net profit declined to ₹4.89 crore from ₹6.88 crore in the same period last year. The company is also increasing its authorized share capital to ₹40 crore to facilitate the bonus issuance. These developments follow a recent ₹49.92 crore rights issue aimed at funding a Greenfield Project at Pen, signaling aggressive expansion.
Key Highlights
Approved 1:1 Bonus Issue by capitalizing free reserves and securities premium of ₹17.48 crore.
Standalone Q3 FY26 revenue from operations rose to ₹44.67 crore versus ₹16.51 crore in Q3 FY25.
Net profit for the quarter stood at ₹4.89 crore, impacted by higher material costs and export commissions.
Authorized share capital increased from ₹25 crore to ₹40 crore to accommodate the new equity base.
Recently completed a ₹49.92 crore rights issue in August 2025 for capital expenditure on a Greenfield Project.
👀 What to Watch
The 1:1 bonus issue is a positive signal for retail liquidity, though investors should monitor the compression in net profit margins despite the high revenue growth. The progress of the Greenfield Project at Pen will be the primary driver for long-term value creation.
Kilitch Drugs Announces 1:1 Bonus Issue and Reports Q3 FY26 Results
Kilitch Drugs (India) Limited has approved a 1:1 bonus issue, meaning shareholders will receive one additional share for every one share held. The company reported standalone net sales of ₹44.67 crore for Q3 FY26, a significant jump from ₹16.51 crore in the same quarter last year. However, net profit for the quarter declined to ₹4.89 crore from ₹6.88 crore YoY, primarily due to a high base of 'Other Income' in the previous year. The board also approved increasing the authorized share capital from ₹25 crore to ₹40 crore to facilitate this corporate action.
Key Highlights
Approved 1:1 bonus issue of equity shares of face value ₹10 each
Standalone Net Sales grew to ₹44.67 crore in Q3 FY26 from ₹16.51 crore in Q3 FY25
Net Profit after tax stood at ₹4.89 crore for the quarter ended December 31, 2025
Authorized share capital increased to ₹40 crore from ₹25 crore subject to member approval
Estimated completion date for bonus share credit is April 10, 2026
👀 What to Watch
The 1:1 bonus issue will increase liquidity and make the stock more affordable for retail investors, though it does not change the company's fundamental value. Investors should monitor the strong growth in core operational revenue while keeping an eye on the volatility of non-operating income.
